arrow_back Back to App

End Tuberculosis Now Act: US Global Action Against TB

This act aims to strengthen US global efforts in combating tuberculosis, a disease that remains a significant public health threat worldwide. It focuses on improving TB diagnosis, treatment, and prevention, including drug-resistant forms, through increased funding, international coordination, and the development of new tools. For citizens, this means a potentially safer world by reducing the risk of infectious disease spread and strengthening global healthcare systems.
Key points
Increased US financial support for global tuberculosis programs, including research into new drugs and vaccines.
Strengthened coordination between US government agencies and international organizations for more effective TB control.
Prioritization of diagnosis and treatment for all forms of TB, including drug-resistant, and prevention of new infections.
Support for high-burden countries in building stronger healthcare systems capable of detecting and treating the disease.
Requirement for regular reporting on progress in the fight against TB, ensuring transparency and accountability for funds spent.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_8654
Sponsor: Rep. Bera, Ami [D-CA-7]
Process start date: 2022-08-05
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

End Tuberculosis Now Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8654.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-08-05.

What are the main provisions?

Key points include:

  • Increased US financial support for global tuberculosis programs, including research into new drugs and vaccines.
  • Strengthened coordination between US government agencies and international organizations for more effective TB control.
  • Prioritization of diagnosis and treatment for all forms of TB, including drug-resistant, and prevention of new infections.
  • Support for high-burden countries in building stronger healthcare systems capable of detecting and treating the disease.
  • Requirement for regular reporting on progress in the fight against TB, ensuring transparency and accountability for funds spent.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Bera, Ami [D-CA-7].

What is the latest detailed status?

The latest detailed status is: Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health